Vivian Tan MD
@drviviantan
Followers
242
Following
123
Statuses
51
Radiation Oncology Resident @SchulichMedDent @WesternU
Joined December 2022
RT @EurUrolOncol: Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Includin…
0
13
0
ORIoN Oncology Research Internship pairs @SchulichMedDent medical students with resident mentors in writing an #oncology case report 📝 Congratulations to all of our students who presented at ORIoN Research Night ⭐️ #MedEd #radonc #medonc #heme #research @LHSCCanada
0
4
19
RT @CTVLondon: 'Music is good for the soul': A holiday concert warms spirits inside the Verspeeten Family Cancer Centre
0
2
0
Incredible experience at #ASTRO2024 in Washington DC 🏛️! Grateful for the opportunity to explore the latest advancements in #radonc and for all the new connections made. Leaving inspired and energized! 💪 Looking forward to the next!
0
1
20
RT @ARRO_org: We ❤️ @ASTRO_org! Thanks to everyone for yet another annual conference in the books! We had so much fun at #ASTRO24 and at…
0
8
0
RT @ASTRO_org: This new #RedJournal article from Tan et al was presented recently at #ASTRO24 during the Scientific Session 32. Read their…
0
8
0
RT @gerryhanna: Dicussant @SBRT_CR reviews the MISSILE study presented by @drviviantan at @ASTRO24 ➡️makes the point that the incomplete p…
0
4
0
Presented 🚀 MISSILE 🚀 at #ASTRO2024 Combined ☢️ #SABR and 🔪 #surgery in early 🫁 #NSCLC was safe with reasonable clinical outcomes, but similar to surgery alone 🚨 Publication in RED journal here @drdavidpalma @DrAlexLouie @DrCorreaRO @TimkWin
1
20
56
👤 NRG-HN005 presented during plenary at #ASTRO2024 #radonc @sueyom 1️⃣ Arm 1: 70 Gy + cisplatin - PFS 98.1% 2️⃣ Arm 2: 60 Gy + cisplatin - PFS 88.6% 3️⃣ Arm 3: 60 Gy + nivolamab - PFS 90.3% ➡️ SOC remains 70 Gy + cisplatin
0
19
58
#kidney #SABR takes center stage at the presidential symposium at #ASTRO2024 @_ShankarSiva ✅ Optimal dose regimen ✅ Role of post-treatment kidney biopsy ✅ SABR in the solitary kidney ✅ Optimal post-treatment follow-up 👏 #SABR for RCC ready for prime time
0
6
30
@SondosZayedMD presenting OPTIMAL at #ASTRO2024 Opioid vs MMA in H&N #cancer 👤 💡 mean pain score during last 7 days RT Opioid 5.10 vs MMA 4.85 (non-inferiority p=0.039, superiority p=0.724) @drdavidpalma @pencilla @DrCorreaRO @goodmanC_MD
0
2
13
RT @AArifinMD: Strong oral presentations by @SchulichMedDent @LHSCCanada #radonc #residents at #caroasm2024!
0
1
0
📋Universal definitions are recommended to ensure consistency in reporting and comparability of future studies
0
0
3
RT @ACRORadOnc: "Impact of the #COVID19 Pandemic on Academic Productivity in Oncology," authored by ACRO member @drviviantan and colleagues…
0
2
0
Had the pleasure of mentoring a medical student in publishing a case report through the @SchulichMedDent ORIoN (#Oncology #Research #Internship) program! Congratulations Josh! 📝
"Malignant Phyllodes Tumors of the Breast With Rhabdomyosarcomatous Differentiation: Case Report & Literature Review" by @ACROresident member @drviviantan w/ colleagues Drs. Joshua Neposlan, @egoebs, Michael Lock & @Dr_RDinniwell is now published on CURiE:
1
1
6
and support of all collaborators! @dr_alimuhammad @AMuacevic @LPonsky @SimonLo21054188 @ASwaminathMD @dr_cury @MichaelStaehler @NicholasZaorsky
1
1
6